Literature DB >> 11318487

Benefit of a digital feedback suppression system for acoustical telephone communication.

M Latzel1, T M Gebhart, J Kiessling.   

Abstract

Because hearing instruments have traditionally performed poorly during acoustical telephone use, the benefit of using a Digital Feedback Suppression (DFS) system for acoustical telephone communication was evaluated. For this purpose a special speech test based on the method and material of the Oldenburg Sentence Test was developed, presenting the speech signal via a telephone receiver. The correct coupling of the receiver and the hearing aid was monitored by means of a probe microphone. The word score was determined for two different settings of the hearing aid: (1) DFS activated (2) DFS deactivated. The difference in word score between these two conditions is an indication of the benefit provided by the DFS system. For almost all subjects, speech recognition at the telephone could be improved using the DFS system. This is a significant contribution in increasing end-user overall satisfaction with hearing aids.

Mesh:

Year:  2001        PMID: 11318487     DOI: 10.1080/010503901300007100

Source DB:  PubMed          Journal:  Scand Audiol Suppl        ISSN: 0107-8593


  3 in total

Review 1.  Challenges and recent developments in hearing aids. Part II. Feedback and occlusion effect reduction strategies, laser shell manufacturing processes, and other signal processing technologies.

Authors:  King Chung
Journal:  Trends Amplif       Date:  2004

2.  Speech perception benefits of internet versus conventional telephony for hearing-impaired individuals.

Authors:  Georgios Mantokoudis; Patrick Dubach; Flurin Pfiffner; Martin Kompis; Marco Caversaccio; Pascal Senn
Journal:  J Med Internet Res       Date:  2012-07-16       Impact factor: 5.428

3.  Wireless and acoustic hearing with bone-anchored hearing devices.

Authors:  Arjan J Bosman; Emmanuel A M Mylanus; Myrthe K S Hol; Ad F M Snik
Journal:  Int J Audiol       Date:  2016-05-13       Impact factor: 2.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.